NCT05740293View on ClinicalTrials.gov

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

CompletedOBSERVATIONAL
Enrollment

186

Participants

Timeline

Start Date

April 5, 2022

Primary Completion Date

September 1, 2024

Study Completion Date

August 25, 2025

Conditions
MyopiaAstigmatism
Interventions
PROCEDURE

VisuMax SMILE procedure for the reduction or elimination of myopia with astigmatism

Bilateral treatment with the approved VisuMax SMILE procedure for the reduction or elimination of myopia with astigmatism.

Trial Locations (7)

21045

Goel Vision, Columbia

44141

Cleveland Eye Clinic, Brecksville

66211

Discover Vision Centers, Leawood

72704

Vold Vision, Fayetteville

78229

Parkhurst NuVision, San Antonio

91748

IQ Laser Vision, Rowland Heights

98125

Northwest Eye Surgeons, Seattle

Sponsors
All Listed Sponsors
lead

Carl Zeiss Meditec, Inc.

INDUSTRY

NCT05740293 - Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure | Biotech Hunter | Biotech Hunter